Biochemical Pharmacology, Department of Biology, University of Konstanz, Konstanz, Germany.
IUBMB Life. 2021 Mar;73(3):592-610. doi: 10.1002/iub.2386. Epub 2020 Sep 15.
Liver receptor homolog-1 (LRH-1, NR5A2) is an orphan nuclear receptor with widespread activities in the regulation of development, stemness, metabolism, steroidogenesis, and proliferation. Many of the LRH-1-regulated processes target the mitochondria and associated activities. While under physiological conditions, a balanced LRH-1 expression and regulation contribute to the maintenance of a physiological equilibrium, deregulation of LRH-1 has been associated with inflammation and cancer. In this review, we discuss the role and mechanism(s) of how LRH-1 regulates metabolic processes, cell survival, and cancer in a nuclear-mitochondrial crosstalk, and evaluate its potential as a pharmacological target.
肝受体同源物-1(LRH-1,NR5A2)是一种孤儿核受体,在发育、干细胞特性、代谢、类固醇生成和增殖的调节中具有广泛的活性。LRH-1 调节的许多过程都针对线粒体及其相关活动。虽然在生理条件下,平衡的 LRH-1 表达和调节有助于维持生理平衡,但 LRH-1 的失调与炎症和癌症有关。在这篇综述中,我们讨论了 LRH-1 如何在核-线粒体串扰中调节代谢过程、细胞存活和癌症的作用和机制,并评估了它作为药理学靶点的潜力。